Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease

Figure 1 PRISMA flowchart for study identification, selection, and inclusion process. NAFLD: Nonalcoholic fatty liver disease.

Figure 2 Forest plot showing the odds of advanced fibrosis with sarcopenia in patients with non-alcoholic fatty liver disease with subgroup analysis based on the method of fibrosis assessment. OR: Odds ratio; 95%CI: 95% confidence interval; FIB-4: Fibrosis-4; NFS/BARD: Non-alcoholic fatty liver disease fibrosis scores/body mass index, the ratio of aspartate aminotransferase to alanine aminotransferase, diabetes; DL: DerSimonian and Laird.